Literature DB >> 20147857

Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas.

Dan-Ning Hu1, Guo-Pei Yu, Steven A McCormick.   

Abstract

Little is known on the difference in the incidence of vulvar and vaginal melanomas in various racial/ethnic groups. Population-based incidence of these melanomas in Asian and Hispanic individuals is almost unknown. Using 1992-2005 data provided by the National Cancer Institute's Surveillance, Epidemiology, and End Results Program, we calculated age-adjusted incidence rates of vulvar and vaginal melanomas in various racial/ethnic groups. From 1992 to 2005, there were 324 vulvar melanomas and 125 vaginal melanomas diagnosed in this group. The annual age-adjusted incidence rates (per million female population) of vulvar and vaginal melanomas in the different racial/ethnic groups was 0.87 (Blacks), 0.75 (American-Indian), 1.03 (Asians and Pacific Islanders), 1.22 (Hispanics), and 1.90 (non-Hispanic Whites). The overall white/black incidence ratio in vulvar and vaginal melanomas was 3.14 : 1 and 1.02 : 1, respectively; which is much less than that of cutaneous melanoma (13 : 1-17 : 1) and uveal melanoma (18 : 1) and is similar to that of conjunctival melanoma (2.6 : 1) and other mucosal melanomas (2.1 : 1-2.3 : 1). The low racial difference in vulvar and vaginal melanomas (as well as conjunctival and other mucosal melanomas) may be determined by their microenvironment factors (all originate from mucosa or semi-mucosa tissues). The incidence of vulvar and vaginal melanomas has does not increased in recent decades or toward the south (more sun exposure), indicating that ultraviolet radiation is not a causative factor in these melanomas. The slight decrease of incidence of vulvar melanoma in dark pigmented individuals may be related to the biochemical protective effects of melanin (as an antioxidant) rather than their photo-screen effects.

Entities:  

Mesh:

Year:  2010        PMID: 20147857     DOI: 10.1097/CMR.0b013e32833684e8

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  16 in total

1.  Primary Vaginal Melanoma, A Rare and Aggressive Entity. A Case Report and Review of the Literature.

Authors:  Emmanouil Kalampokas; Theodoros Kalampokas; Christos Damaskos
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

2.  Malignant Melanoma of Vagina: A Report and Review of Literature.

Authors:  Sangeeta Pankaj; Anjili Kumari; Syed Nazneen; Vijayanand Choudhary; Simi Kumari
Journal:  J Obstet Gynaecol India       Date:  2015-09-11

Review 3.  Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management.

Authors:  Dongying Wang; Tianmin Xu; He Zhu; Junxue Dong; Li Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

4.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

5.  A Thirty-year Review of Vulvar Cancer in Jamaica, 1978 to 2007.

Authors:  M E Bromfield; T N Gibson; B Hanchard; N Waugh; D McNaughton
Journal:  West Indian Med J       Date:  2014-04-11       Impact factor: 0.171

6.  Primary malignant melanoma of the vagina: A case report and review of literature.

Authors:  Snehamay Chaudhuri; Diptimay Das; Soham Chowdhury; Anjan Das Gupta
Journal:  South Asian J Cancer       Date:  2013-01

7.  New trends in dermoscopy to minimize the risk of missing melanoma.

Authors:  Aimilios Lallas; Zoe Apalla; Georgios Chaidemenos
Journal:  J Skin Cancer       Date:  2012-10-08

Review 8.  Melanoma risk perception and prevention behavior among African-Americans: the minority melanoma paradox.

Authors:  Alina Goldenberg; Igor Vujic; Martina Sanlorenzo; Susana Ortiz-Urda
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-08-05

9.  Vaginal primary malignant melanoma: a rare and aggressive tumor.

Authors:  Georgios Androutsopoulos; Emmanouil Terzakis; Georgia Ioannidou; Athanasios Tsamandas; Georgios Decavalas
Journal:  Case Rep Obstet Gynecol       Date:  2013-07-22

Review 10.  A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker.

Authors:  Viola A Heinzelmann-Schwarz; Sheri Nixdorf; Mehrnaz Valadan; Monica Diczbalis; Jake Olivier; Geoff Otton; André Fedier; Neville F Hacker; James P Scurry
Journal:  Int J Mol Med       Date:  2014-02-14       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.